Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance—Does Magnetic Resonance Imaging Have a Role?
The National Comprehensive Cancer Network recommends that selected men with grade group 2 prostate cancer be considered for active surveillance. The information could be used to inform biopsy strategy, counsel patients, on treatment options, and guide strategies for those on active surveillance.
